Muta-mycosynthesis of naphthalene analogs

Org Lett. 2015 Mar 20;17(6):1457-60. doi: 10.1021/acs.orglett.5b00335. Epub 2015 Mar 6.

Abstract

A mutasynthetic strategy is introduced for the mycosynthesis of naphthalene-based molecules (mutadalesols A-F) with directed substitution patterns and new frameworks by generating and using the ΔpksTL mutant strain of Daldinia eschscholzii. (±)-Mutadalesol A and its (+)-enantiomer are cytotoxic, and its (-)-enantiomer inhibits Toll-like receptor 5 (TLR5). The in-culture reactability of fungal oligoketide intermediates with 5-aminonaphthalen-1-ol (ANL) is demonstrated, shedding light on bioorthogonal accesses to unnatural molecule libraries valuable in drug discovery pipelines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism*
  • Antineoplastic Agents / pharmacology
  • Ascomycota / chemistry*
  • Ascomycota / genetics
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Structure
  • Naphthalenes / chemistry
  • Naphthalenes / metabolism*
  • Naphthalenes / pharmacology
  • Nuclear Magnetic Resonance, Biomolecular
  • Stereoisomerism
  • Toll-Like Receptor 5 / drug effects

Substances

  • Antineoplastic Agents
  • Naphthalenes
  • Toll-Like Receptor 5
  • mutadalesol A